Product Code: 5279
The sleep apnea implants market is set to grow steadily by 2030 owing to surging number of sleep apnea patients. In addition, rising awareness about sleep apnea disorders and expanding geriatric population with sleep apnea are likely to facilitate market growth through the forecast period.
During the COVID-19 pandemic, the industry witnessed a setback in business operations due to restrictions on movement and a strong focus on developing effective treatments for the coronavirus infection. However, the post-pandemic scenario has fueled market progress as a result of growing awareness pertaining to sleep apnea.
Various government initiatives, along with significant investments by public and private companies in the field, have also boosted consumer interest in the product. For instance, in February 2021, the U.S. FDA approved a tongue muscle stimulation device eXciteOSA that claims to calm mild sleep apnea in the user's waking hours. The device is the first to improve tongue muscle function during daytime, which can eventually treat tongue movement and prevent obstructive sleep apnea at night.
Notably, major players in the industry are investing in innovations in sleep apnea implant technology, coupled with growth strategies like acquisitions and partnerships, thereby fostering business growth. For instance, in April 2022, Natus Medical Incorporated, a provider of medical treatment solutions, announced that it has inked an agreement to be acquired by Archimed Group, a leading healthcare investment firm, for around $1.2 billion. Under the terms of the agreement, Natus shareholders were set to receive $33.50 in cash for each share.
The sleep apnea implants market has been bifurcated based on end-use, product, indication, and region.
In terms of product, the industry has been divided into palatal implants, bone screw system, phrenic nerve stimulator, and hypoglossal neurostimulation devices. The phrenic nerve stimulator sub-segment registered a valuation of above $24 million in 2021 as a result of increasing adoption of phrenic nerve stimulators for central sleep apnea management.
With regards to indication, the sleep apnea implants market has been split into central sleep apnea and obstructive sleep apnea. The obstructive sleep apnea or OSA sub-segment accounted for over 92% of the market revenue in 2021 attributed to surging awareness regarding obstructive sleep apnea, rising number of disease-affected people, and availability of several treatment alternatives for the condition.
The industry has been segmented based on end-use into ambulatory surgical centers, hospitals, and others. The ambulatory surgical centers sub-segment was valued at around $128 million in 2021 due to the feasible reimbursement coverage and availability of latest surgical technologies that promote patient satisfaction and convenience.
In the regional frame of reference, apart from Europe and North America, the RoW sleep apnea implants market is expected to grow at a CAGR of approximately 19.2% through the study time span. Rising prevalence of sleep apnea, increased adoption of sleep apnea implants, and soaring awareness about the disease are slated to fuel regional market growth in the future.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definition
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Sleep apnea implants industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Indication trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Sleep Apnea Implant Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030 (USD Million)
- 3.3 Industry impact factors
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing prevalence of obstructive sleep apnea
- 3.3.1.2 Low compliance & adherence towards CPAP
- 3.3.1.3 Technological advancements
- 3.3.1.4 Increasing awareness regarding sleep apnea
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High costs of sleep apnea implants
- 3.3.2.2 Complications associated with sleep apnea implants
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By indication
- 3.4.3 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Regulatory landscape
- 3.7 Reimbursement landscape
- 3.8 Pipeline analysis
- 3.9 Patient journey map
- 3.10 Porter's analysis
- 3.11 Competitive landscape, 2021
- 3.11.1 Company matrix analysis, 2021
- 3.12 PESTEL analysis
Chapter 4 Sleep Apnea Implants Market, By Product
- 4.1 Key segment trends
- 4.2 Hypoglossal Neurostimulation Devices
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Market size, by region, 2017 - 2030 (Units)
- 4.3 Palatal Implants
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.2 Market size, by region, 2017 - 2030 (Units)
- 4.4 Bone screw system
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.2 Market size, by region, 2017 - 2030 (Units)
- 4.5 Phrenic Nerve Stimulator
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5.2 Market size, by region, 2017 - 2030 (Units)
Chapter 5 Sleep Apnea Implants Market, By Indication
- 5.1 Key segment trends
- 5.2 Central sleep apnea
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Obstructive sleep apnea
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Sleep Apnea Implants Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Ambulatory surgical centers
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Others
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Sleep Apnea Implants Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by country, 2017 - 2030 (Units)
- 7.2.3 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by product, 2017 - 2030 (Units)
- 7.2.5 Market size, by indication, 2017 - 2030 (USD Million)
- 7.2.6 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.7 U.S.
- 7.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.7.2 Market size, by product, 2017 - 2030 (Units)
- 7.2.7.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.8 Canada
- 7.2.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.8.2 Market size, by product, 2017 - 2030 (Units)
- 7.2.8.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.2.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by country, 2017 - 2030 (Units)
- 7.3.3 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by product, 2017 - 2030 (Units)
- 7.3.5 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.6 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.7 Germany
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.7.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.8 UK
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.8.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.9 France
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.9.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.10 Spain
- 7.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.10.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.10.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.11 Italy
- 7.3.11.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.11.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.11.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.11.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.12 The Netherlands
- 7.3.12.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.12.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.12.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.12.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.13 Switzerland
- 7.3.13.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.13.2 Market size, by product, 2017 - 2030 (Units)
- 7.3.13.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.13.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4 RoW
- 7.4.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (Units)
- 7.4.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2021
- 8.2 Inspire Medical Systems, Inc.
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
- 8.3 Medtronic plc
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
- 8.4 Nyxoah SA
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
- 8.5 Siesta Medical
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6 Respicardia, Inc. (Asahi Kasei Company)
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 LivaNova
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis